{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:56:11Z","timestamp":1792605371945,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jchf.2023.02.006","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T14:30:00Z","timestamp":1681914600000},"page":"760-771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["SERCA2a Agonist Effects on Cardiac\u00a0Performance During Exercise\u00a0in\u00a0Heart\u00a0Failure With Preserved\u00a0Ejection Fraction"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0628-4919","authenticated-orcid":false,"given":"Satyam","family":"Sarma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"MacNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3434-6184","authenticated-orcid":false,"given":"Michinari","family":"Hieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6657-4395","authenticated-orcid":false,"given":"Erin J.","family":"Howden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin S.","family":"Lawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchel","family":"Samels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin D.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2023.02.006_bib1","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/S0140-6736(16)00704-2","article-title":"A\u00a0transcatheter intracardiac shunt device for heart failure with preserved ejection fraction (REDUCE LAP-HF): a multicentre, open-label, single-arm, phase 1 trial","volume":"387","author":"Hasenfuss","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2023.02.006_bib2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/CIRCRESAHA.116.309184","article-title":"Inhaled sodium nitrite improves rest and exercise hemodynamics in heart failure with preserved ejection fraction","volume":"119","author":"Borlaug","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2023.02.006_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCHEARTFAILURE.109.867044","article-title":"Characterization of static and dynamic left ventricular diastolic function in patients with heart failure with a preserved ejection fraction","volume":"3","author":"Prasad","year":"2010","journal-title":"Circ Heart Fail"},{"issue":"suppl A","key":"10.1016\/j.jchf.2023.02.006_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/1.suppl_1.119","article-title":"Quantification of incomplete left ventricular relaxation: relationship to the time constant for isovolumic pressure fall","author":"Weisfeldt","year":"1980","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2023.02.006_bib5","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev.physiol.70.113006.100455","article-title":"Calcium cycling and signaling in cardiac myocytes","volume":"70","author":"Bers","year":"2008","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jchf.2023.02.006_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/circ.105.3.272","article-title":"Progression of heart failure: is protein kinase a hyperphosphorylation of the ryanodine receptor a contributing factor?","volume":"105","author":"Marks","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2023.02.006_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1124\/jpet.108.138701","article-title":"Modulation of sarcoplasmic reticulum function by PST2744 [istaroxime; (E,Z)-3-((2-aminoethoxy)imino) androstane-6,17-dione hydrochloride)] in a pressure-overload heart failure model","volume":"326","author":"Rocchetti","year":"2008","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jchf.2023.02.006_bib8","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ahj.2009.03.007","volume":"157","author":"Shah","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2023.02.006_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006331","article-title":"Mechanisms of chronotropic incompetence in heart failure with preserved ejection fraction","volume":"13","author":"Sarma","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2023.02.006_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1152\/japplphysiol.01106.2006","article-title":"Simultaneous determination of the accuracy and precision of closed-circuit cardiac output rebreathing techniques","volume":"103","author":"Jarvis","year":"2007","journal-title":"J\u00a0Appl Physiol"},{"key":"10.1016\/j.jchf.2023.02.006_bib11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0002-8703(92)90416-S","article-title":"Isovolumic relaxation time varies predictably with its time constant and aortic and left atrial pressures: implications for the noninvasive evaluation of ventricular relaxation","volume":"124","author":"Thomas","year":"1992","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2023.02.006_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jchf.2023.02.006_bib13","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.jacc.2008.03.015","article-title":"Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure","volume":"51","author":"Gheorghiade","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2023.02.006_bib14","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/ejhf.1743","article-title":"Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial","volume":"22","author":"Carubelli","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2023.02.006_bib15","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.022889","article-title":"Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure","volume":"124","author":"Jessup","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2023.02.006_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jacc.2009.03.037","article-title":"The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion","volume":"54","author":"Tan","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2023.02.006_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ehf2.12049","article-title":"Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction","volume":"2","author":"Kasner","year":"2015","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2023.02.006_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jacc.2010.10.069","article-title":"Tachycardia-induced diastolic dysfunction and resting tone in myocardium from patients with a normal ejection fraction","volume":"58","author":"Selby","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2023.02.006_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jacc.2020.11.044","article-title":"Etiology-dependent impairment of diastolic cardiomyocyte calcium homeostasis in heart failure with preserved ejection fraction","volume":"77","author":"Frisk","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2023.02.006_bib20","doi-asserted-by":"crossref","first-page":"47A","DOI":"10.1016\/j.amjcard.2006.09.006","article-title":"A\u00a0phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function","volume":"99","author":"Ghali","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2023.02.006_bib21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/cvr\/cvx087","article-title":"Increased passive stiffness promotes diastolic dysfunction despite improved Ca2+ handling during left ventricular concentric hypertrophy","volume":"113","author":"Roe","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2023.02.006_bib22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/cvr\/cvx047","article-title":"Impact of acute hypertension transients on diastolic function in patients with heart failure with preserved ejection fraction","volume":"113","author":"Perez Del Villar","year":"2017","journal-title":"Cardiovasc Res"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177923000902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177923000902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:03:10Z","timestamp":1761973390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177923000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2213177923000902"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2023.02.006","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SERCA2a Agonist Effects on Cardiac\u00a0Performance During Exercise\u00a0in\u00a0Heart\u00a0Failure With Preserved\u00a0Ejection Fraction","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2023.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}